Genesis Healthcare, Inc.
GEN
GEN was delisted on the 25th of March, 2021.
77 hedge funds and large institutions have $46.6M invested in Genesis Healthcare, Inc. in 2018 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 29 increasing their positions, 23 reducing their positions, and 15 closing their positions.
26% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 23
6% less funds holding
Funds holding: 82 → 77 (-5)
33% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 15
34% less capital invested
Capital invested by funds: $70.9M → $46.6M (-$24.3M)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VCM
V3 Capital Management
Dallas,
Texas
|
+$1.65M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.05M |
| 3 |
Renaissance Technologies
New York
|
+$747K |
| 4 |
FWC
First Washington Corp
Seattle,
Washington
|
+$723K |
| 5 |
CPA
Columbia Pacific Advisors
Seattle,
Washington
|
+$711K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$985K |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
-$813K |
| 3 |
EI
EAM Investors
Solana Beach,
California
|
-$783K |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$670K |
| 5 |
JP Morgan Chase
New York
|
-$533K |
GEN Hedge Fund Activity: Q3 2018 in Review
77 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Genesis Healthcare, Inc. (GEN) for Q3 2018, worth a combined $46.6M — down 34% from $70.9M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of GEN and 10 opened new positions — a net loss of 5 holders — while 23 trimmed existing stakes and 29 added.
The largest buyer was V3 Capital Management, adding an estimated $1.65M. The largest seller was Panagora Asset Management, cutting an estimated $985K.
- 77 institutional investors held Genesis Healthcare, Inc. (GEN) as of Q3 2018, down from 82 in Q2 2018.
- Funds reported $46.6M of Genesis Healthcare, Inc. stock for Q3 2018, down 34% quarter-over-quarter.
- 10 funds opened new Genesis Healthcare, Inc. positions in Q3 2018 and 15 closed out, a net change of -5 holders.
- The largest Genesis Healthcare, Inc. buyer in Q3 2018 was V3 Capital Management, an estimated $1.65M added.
- The largest Genesis Healthcare, Inc. seller in Q3 2018 was Panagora Asset Management, an estimated $985K sold.
Based on aggregated 13F filings for Q3 2018.